2015
DOI: 10.1136/heartjnl-2015-307930
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis

Abstract: This study shows a significantly lower incidence of TE after Fontan procedure if either aspirin or warfarin is used. This meta-analysis suggests no significant difference in incidence of early or late TE in patients receiving aspirin compared with warfarin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
81
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 109 publications
(87 citation statements)
references
References 35 publications
3
81
1
1
Order By: Relevance
“…Risk factors for thrombosis include haemodynamic factors with low cardiac output and less pulsatile pulmonary flow in addition to a hypercoagulable state in Fontan patients 29. A recent meta-analysis showed a pooled incidence of 11% and that prophylaxis with aspirin or warfarin decreases the risk significantly (OR 0.4, 95% CI 0.19 to 0.92) 29. The location of thrombus is most commonly in the Fontan conduit, intracardiac or in the pulmonary arteries 15 29 30…”
Section: Predictors Of Long-term Mortalitymentioning
confidence: 99%
“…Risk factors for thrombosis include haemodynamic factors with low cardiac output and less pulsatile pulmonary flow in addition to a hypercoagulable state in Fontan patients 29. A recent meta-analysis showed a pooled incidence of 11% and that prophylaxis with aspirin or warfarin decreases the risk significantly (OR 0.4, 95% CI 0.19 to 0.92) 29. The location of thrombus is most commonly in the Fontan conduit, intracardiac or in the pulmonary arteries 15 29 30…”
Section: Predictors Of Long-term Mortalitymentioning
confidence: 99%
“…241 There is no consensus as to whether antiplatelet therapy is adequate or therapeutic anticoagulation is needed in the absence of previous thromboembolism or arrhythmia, but limited data suggest equal efficacy of either strategy. 241,242 The relative safety and efficacy of non-vitamin K antagonist oral anticoagulants in adults with CHD have not been established, but multicenter trials are ongoing.…”
Section: 240mentioning
confidence: 99%
“…In addition to the aforementioned sluggish blow flow through the Fontan circuit, a hypercoagulable state develops in patients following the procedure: the levels of protein C, protein S and antithrombin III are low, while the level of factor VIII is elevated 14. The pathogenesis behind this imbalance is not fully understood.…”
Section: Discussionmentioning
confidence: 99%